| Dr John Beveridge Parkerson Jr, MD | |
|
4717 Falls Rd, Baltimore, MD 21209-4908 | |
| (410) 366-3627 | |
| (410) 366-1183 |
| Full Name | Dr John Beveridge Parkerson Jr |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 4717 Falls Rd, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730299678 | NPI | - | NPPES |
| C1-0005889 | Other | DE | STATE PHYSICIAN LICENSE |
| D32875 | Other | MD | STATE PHYSIAN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | D32875 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Beveridge Parkerson Jr, MD 4717 Falls Rd, Baltimore, MD 21209-4908 Ph: (410) 366-3627 | Dr John Beveridge Parkerson Jr, MD 4717 Falls Rd, Baltimore, MD 21209-4908 Ph: (410) 366-3627 |
News Archive
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML)
Scientists have improved upon their own previous world-best efforts to pluck out just the right stem cells to address the brain problem at the core of multiple sclerosis and a large number of rare, fatal children's diseases.
Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.
The study showed that, compared with the control group, the veterinarians who worked with birds had significantly higher levels of antibodies in their blood against the H5, H6 and H7 avian virus strains, indicating previous infections with these viruses.
Antibodies protect the body against diseases - but can also harm their own organism if the reactions are misdirected. Researchers from the University of Zurich have now discovered that a particular sugar in the antibodies determines whether one of the body's own cells is destroyed or not. This result could lead to new treatment possibilities for patients with autoimmune diseases.
› Verified 6 days ago
Dr. Ken Lin Tai, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 W Preston St, Room 304b, Baltimore, MD 21201 Phone: 410-767-2036 | |
James D Levy, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 323 N Calvert St, Baltimore, MD 21202 Phone: 410-332-9240 Fax: 410-962-8398 | |
Dr. Eileen Karen Steinberger, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 660 W Redwood St, Sutie 100d, Baltimore, MD 21201 Phone: 410-767-0789 Fax: 410-333-5210 | |
Dr. Jorge Ernesto Calderon, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4000 Annapolis Rd, Suite 201, Baltimore, MD 21227 Phone: 410-636-2222 Fax: 410-789-4688 | |
Dr. Taiwo Olubanke Lawoyin, MD, MPH, CPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Armory Pl, Suite 3m, Baltimore, MD 21201 Phone: 410-225-8615 | |
Dr. Paul B Spiegel, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 615 N Wolfe St, Baltimore, MD 21205 Phone: 443-326-8050 | |
Shelly Seungah Choo, M.D., M.P.H Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 E Fayette St, Baltimore, MD 21202 Phone: 410-396-1834 |